HSTM
$27.99
Healthstream
$.14
.50%
Earnings Details
4th Quarter December 2018
Tuesday, February 19, 2019 4:30:00 PM
Tweet Share Watch
Summary

HealthStream Sees Revenue Above Estimates

Healthstream (HSTM) reported 4th Quarter December 2018 earnings of $0.09 per share on revenue of $59.8 million. The consensus earnings estimate was $0.05 per share on revenue of $57.8 million. Revenue fell 4.7% compared to the same quarter a year ago.

The company said it expects 2019 revenue of $251.0 million to $258.0 million. The current consensus estimate is revenue of $244.6 million for the year ending December 31, 2019.

HealthStream Inc provides SaaS-based workforce development solutions and research/patient experience solutions for healthcare organizations. It provides HealthStream Workforce Development Solutions & HealthStream Research/Patient Experience Solutions.

Results
Reported Earnings
$0.09
Earnings Whisper
-
Consensus Estimate
$0.05
Reported Revenue
$59.8 Mil
Revenue Estimate
$57.8 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

HealthStream Announces Fourth Quarter & Full-Year 2018 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthStream, Inc. (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, announced today results for the fourth quarter and full-year ended December 31, 2018. In this earnings release, (i) all results are from continuing operations only (i.e., 2017 and 2018 results exclude the gain on the sale of our divested Patient Experience business segment which was completed in February 2018 and the results of operations of such segment prior to this divestiture) and (ii) 2018 results are presented in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers (ASC 606), whereas results for 2017 are presented in accordance with ASC 605.

Fourth Quarter 2018

  • Revenues of $59.8 million in the fourth quarter of 2018, up 8% from $55.3 million in the fourth quarter of 2017 with $342,000 negative impact in the fourth quarter of 2018 from the application of ASC 606
  • Operating income of $2.8 million in the fourth quarter of 2018, up 88% from $1.5 million in the fourth quarter of 2017 with $897,000 positive impact in the fourth quarter of 2018 from the application of ASC 606
  • Income from continuing operations of $2.9 million in the fourth quarter of 2018, down 8% from $3.2 million in the fourth quarter of 2017 with $877,000 positive impact in the fourth quarter of 2018 from the application of ASC 606
  • Earnings per share (EPS) from continuing operations of $0.09 per share (diluted) in the fourth quarter of 2018, compared to $0.10 per share (diluted) in the fourth quarter of 2017
  • Adjusted EBITDA1 from continuing operations of $9.5 million in the fourth quarter of 2018, up 16% from $8.2 million in the fourth quarter of 2017 with $897,000 positive impact in the fourth quarter of 2018 from the application of ASC 606

Full-Year 2018

  • Revenues of $231.6 million in 2018, up 8% from $214.9 million in 2017 with $740,000 positive impact in 2018 from the application of ASC 606
  • Operating income of $15.5 million in 2018, up 65% from $9.4 million in 2017 with $3.7 million positive impact in 2018 from the application of ASC 606
  • Income from continuing operations of $13.3 million in 2018, up 50% from $8.8 million in 2017 with $3.0 million positive impact in 2018 from the application of ASC 606
  • EPS from continuing operations of $0.41 per share (diluted) in 2018, compared to $0.27 per share (diluted) in 2017
  • Adjusted EBITDA1 from continuing operations of $41.5 million in 2018, up 18% from $35.2 million in 2017 with $3.7 million positive impact in 2018 from the application of ASC 606

2019 Event

  • On January 10, 2019, acquired Providigm, LLC, a Denver-based company focused on quality assurance and performance improvement in healthcare, primarily serving skilled nursing facilities
 

1 Adjusted EBITDA from continuing operations is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to income from continuing operations and disclosure regarding why we believe adjusted EBITDA from continuing operations provides useful information to investors is included later in this release.

 

Financial Results:
Fourth Quarter 2018 Compared to Fourth Quarter 2017

On January 1, 2018, the Company adopted ASC 606 using the modified retrospective approach. Under this approach, prior period results continue to be presented in accordance with the previous standard of ASC 605. See discussion elsewhere in this release about comparisons with respect to our results under ASC 606 and ASC 605.

Revenues for the fourth quarter of 2018 increased by $4.5 million, or 8 percent, to $59.8 million, compared to $55.3 million for the fourth quarter of 2017.

Revenues from our HealthStream Workforce Solutions segment were approximately $49.1 million for the fourth quarter of 2018, compared to $45.5 million for the fourth quarter of 2017. Revenue growth of $3.6 million from our workforce solutions products was primarily a result of an increase in subscription-based product revenues.

Revenues from our HealthStream Provider Solutions segment were approximately $10.7 million for the fourth quarter of 2018, compared to $9.8 million for the fourth quarter of 2017. Revenue growth of $960,000, net of related deferred revenue write-downs, was primarily due to organic growth among the product lines.

Generally accepted accounting principles (GAAP) require companies to write down beginning balances of acquired deferred revenue balances as part of “fair value” accounting as defined by GAAP. During the fourth quarter of 2018, HealthStream reported a reduction of $108,000 to operating income and a reduction of $86,000 to net income as a result of deferred revenue write-downs from prior acquisitions. During the fourth quarter of 2017, HealthStream reported a reduction of $82,000 to operating income and a reduction of $148,000 to net income as a result of deferred revenue write-downs from prior acquisitions. The table reconciling GAAP to non-GAAP financial measures included in this release shows the impact of beginning balance deferred revenue write-downs on operating income and net income.

Operating income was $2.8 million for the fourth quarter of 2018, up 88 percent from $1.5 million for the fourth quarter of 2017. Operating income was positively impacted by the increase in revenue and by the application of ASC 606 as noted above. The positive impact of these items on operating income was partially offset by higher operating expenses associated with increased royalties, personnel costs, due diligence, and infrastructure investments, but was partially offset by declines in sales commissions and bad debt expense.

Income from continuing operations was $2.9 million in the fourth quarter of 2018, down 8 percent from $3.2 million in the fourth quarter of 2017. Income from continuing operations was lower in 2018 compared to 2017 due to the enactment of the Tax Cuts and Jobs Act that was signed into law on December 22, 2017, which reduced the corporate federal income tax rate from 35% to 21% and positively impacted our net income in the amount of approximately $1.7 million during the fourth quarter of 2017 through the revaluation of our net deferred tax liabilities, resulting in an income tax benefit during the fourth quarter. This change was partially offset by the increase in revenue and the application of ASC 606 as noted above compared to the 2017 period. EPS from continuing operations was $0.09 per share (diluted) in the fourth quarter of 2018, compared to $0.10 per share (diluted) for the fourth quarter of 2017.

Net income (from continuing and discontinued operations) was $2.8 million in the fourth quarter of 2018, compared to $3.9 million in the fourth quarter of 2017. Earnings per share (diluted) were $0.09 per share for the fourth quarter of 2018, compared to $0.12 per share (diluted) for the fourth quarter of 2017. The reduction in net income and earnings per share (diluted) compared to the prior year fourth quarter is attributable to the one-time tax benefits realized during the fourth quarter of 2017.

Adjusted EBITDA from continuing operations increased to $9.5 million for the fourth quarter of 2018, compared to $8.2 million for the fourth quarter of 2017. The application of ASC 606 had a positive impact of $897,000 on Adjusted EBITDA from continuing operations during the fourth quarter of 2018.

At December 31, 2018, the Company had cash and cash equivalents and marketable securities of $168.8 million. Capital expenditures incurred during the fourth quarter of 2018 were approximately $9.9 million.

As discussed in our last earnings conference call, we are retiring the metrics of “implemented and contracted subscribers.” These metrics do not span our entire business and this will be the last time we report them. At December 31, 2018, we had approximately 4,823,000 total subscribers implemented to use and 4,933,000 total subscribers contracted to use our subscription-based solutions. “Contracted subscribers” include both those already implemented and those under contract that are in the process of implementation. Revenue recognition generally commences when a contract is implemented.

We are introducing a new measure of our progress in growing the value of our customer base, “hStream subscriptions.” As of December 31, 2018, we had approximately 1.51 million hStream subscriptions under contract. Our new hStream technologies represent the beginning of our “platform-as-a-service” capabilities, which will, over time, span our entire business.

Full-Year 2018 Compared to Full-Year 2017
For 2018, revenues were $231.6 million, an increase of 8 percent over revenues of $214.9 million for 2017. Operating income for 2018 increased by 65 percent to $15.5 million, compared to $9.4 million for 2017. Income from continuing operations for 2018 increased by 50 percent to $13.3 million, compared to $8.8 million for 2017. Earnings per share from continuing operations were $0.41 per share (diluted) for 2018, compared to $0.27 per share (diluted) for 2017. Net income for 2018 increased to $32.2 million, compared to $10.0 million for 2017, which increase was primarily driven by the $19.0 million gain, net of tax, on the sale of the Patient Experience business in February 2018. Earnings per share were $1.00 per share (diluted) for 2018, compared to $0.31 per share (diluted) for 2017. Adjusted EBITDA from continuing operations increased by 18 percent to $41.5 million for 2018, compared to $35.2 million for 2017. Adjusted EBITDA increased by 87 percent to $71.1 million for 2018, compared to $37.9 million for 2017, which increase was primarily driven by the pre-tax gain on the sale of the Patient Experience business of $29.5 million.

Financial Impact of Adopting ASC 606
The chart on page 11 under the heading of “Impact of Adoption of ASC 606” sets forth what the revenues, operating income, net income from continuing operations, adjusted EBITDA from continuing operations, and non-GAAP operating income would have been for the fourth quarter of 2018 and full-year 2018 if the prior revenue recognition standard was applied (ASC 605).

2019 Event
On January 10, 2019, the Company acquired Providigm, LLC, a Denver-based company focused on quality assurance and performance improvement in healthcare, primarily serving skilled nursing facilities, for $18.0 million in cash. In addition, up to an additional $500,000 in cash may be paid contingent upon the performance of Providigm during an 18-month period following closing. This acquisition adds to the Company’s workforce development solutions with a comprehensive quality management system created by Providigm, known as “abaqis®,” which is the leading SaaS-based quality-improvement program adopted by U.S. skilled nursing facilities. The results of Providigm will be included in the HealthStream Workforce Solutions segment from the date of acquisition.

Financial Outlook for 2019
We are providing 2019 financial guidance as set forth below:

                   

Full Year 2019 Guidance

Revenue:      
Workforce Solutions $ 207 - $ 213 million
Provider Solutions $ 44 - $ 45 million
Consolidated $ 251 - $ 258 million
 
Operating Income $ 10.0 - $ 12.4 million
 
Capital Expenditures $ 35 million
 
Annual Effective Income Tax Rate 26 - 28 percent
 

The above guidance includes the acquisition of Providigm, which was consummated on January 10, 2019 and is included in our Workforce Solutions segment.

During 2019, we anticipate higher operating expenses associated with our new corporate office, which consolidates our middle Tennessee operations; investments in product development and sales of our new resuscitation products; and investments to support the growth and expanded market positioning of solutions attained through the acquisition of Providigm.

We anticipate that capital expenditures associated with our office consolidation to a central location in Nashville, Tennessee will approximate $15 million of the $35 million total estimate during 2019. This consolidated guidance does not include the impact of any other acquisitions that we may complete during 2019.

“Our full-year 2018 financial results reflect a year of solid performance over the prior year with revenues up 8 percent, operating income up 65 percent, and adjusted EBITDA up 18 percent to $41.5 million,” said Robert A. Frist, Jr., Chief Executive Officer, HealthStream. “Our performance positions us well to make investments for long-term growth. Already in 2019, we have invested in new senior leadership, launched major new products, and made a strategic acquisition—all which place us on a growth offensive.”

A conference call with Robert A. Frist, Jr., Chief Executive Officer, Gerard M. Hayden, Jr., Senior Vice President and Chief Financial Officer, and Mollie Condra, Vice President of Investor Relations and Corporate Communications, will be held on Wednesday, February 20, 2019, at 9:00 a.m. (ET). To listen to the conference, please dial 877-647-2842 (no conference ID needed) if you are calling within the domestic U.S. or Canada. If you are an international caller, please dial 914-495-8564 (no conference ID needed). The conference may also be accessed by going to http://ir.healthstream.com/events.cfm for the simultaneous Webcast of the call, which will subsequently be available for replay. The replay telephone numbers are 855-859-2056 (conference ID #1599407) for U.S. and Canadian callers and 404-537-3406 (conference ID #1599407) for international callers.

Use of Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, adjusted EBITDA from continuing operations, and adjusted EBITDA, which are used by management in analyzing the Company’s financial results and ongoing operational performance.

In order to better assess the Company’s financial results, management believes that net income before interest, income taxes, share-based compensation, depreciation and amortization, and changes in fair value of cost method investments (“adjusted EBITDA”) is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for certain non-cash and non-operating items. Effective January 1, 2018, the Company adopted ASU 2016-01, which (among other things) requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. During the three months ended September 30, 2018, the Company recorded a reduction to net income and net income from continuing operations from a change in the fair value of a minority equity investment accounted for under the cost method of accounting. The Company has included this adjustment in the calculation of adjusted EBITDA, and intends to continue to include any positive or negative changes in fair value of cost method investments in the calculation of adjusted EBITDA on a prospective basis, because management believes that such changes do not represent the ongoing operational performance of the Company. Management also believes that adjusted EBITDA from continuing operations is a useful measure for evaluating the operating performance of the Company because such measure excludes the results of operations of the Patient Experience business that we sold in February 2018 and thus reflects the Company’s ongoing business operations and assists in comparing the Company’s results of operations between periods. We also believe that adjusted EBITDA and adjusted EBITDA from continuing operations are useful to many investors to assess the Company’s ongoing results from current operations. Adjusted EBITDA and adjusted EBITDA from continuing operations are non-GAAP financial measures and should not be considered as measures of financial performance under GAAP. Because adjusted EBITDA and adjusted EBITDA from continuing operations are not measurements determined in accordance with GAAP, such non-GAAP financial measures are susceptible to varying calculations. Accordingly, adjusted EBITDA and adjusted EBITDA from continuing operations, as presented, may not be comparable to other similarly titled measures of other companies.

In recent years, the Company has acquired businesses whose net tangible assets include deferred revenue. In accordance with GAAP reporting requirements, following the completion of any such acquisition, the Company may record a write-down of deferred revenue to fair value as defined by GAAP. If the Company is required to record a write-down of deferred revenue, it may result in lower recognized revenue, operating income, and net income in subsequent periods.

In connection therewith, this release presents below non-GAAP operating income and non-GAAP net income, which in each case reflects the corresponding GAAP figures adjusted to exclude the impact of the deferred revenue write-down associated with fair value accounting for acquired businesses as referenced above. Management believes that the presentation of these non-GAAP financial measures assists investors in understanding the Company’s performance between periods, excluding the impact of this deferred revenue write-down, and provides a useful measure of the ongoing performance of the Company. Both on a quarterly and year-to-date basis, the revenue for any acquired business is deferred and typically recognized over a one-to-two year period following the completion of an acquisition, so our GAAP revenues for this one-to-two year period will not reflect the full amount of revenues that would have been reported if the acquired deferred revenue had not been written down to fair value.

These non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance, which are prepared in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Investors are encouraged to review the reconciliations of our GAAP to non-GAAP financial measures, which are set forth below in this release.

About HealthStream
HealthStream (Nasdaq: HSTM) is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Our unified suite of solutions is contracted by, collectively, over 4.9 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, credentialing, privileging, provider enrollment, performance assessment, and managing simulation-based education programs. Based in Nashville, Tennessee, HealthStream currently has additional offices in Brentwood, Tennessee; Jericho, New York; Boulder; Colorado; San Diego, California; Chicago, Illinois; and Denver, Colorado. For more information, visit http://www.healthstream.com or call 800-933-9293.

 
 
 
 
 

HEALTHSTREAM, INC.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)

 
      Three Months Ended

December 31,

  Year Ended

December 31,

2018     2017 2018     2017
Revenues, net $ 59,825 $ 55,269 $ 231,616 $ 214,899
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization) 25,429 22,310 96,014 87,208
Product development 6,586 6,219 25,735 24,148
Sales and marketing 9,161 10,842 35,698 38,606
Other general and administrative expenses 9,678 8,214 34,447 31,483
Depreciation and amortization   6,134     6,173     24,231     24,047  
Total operating costs and expenses 56,988 53,758 216,125 205,492
 
Operating income 2,837 1,511 15,491 9,407
 
Other income, net   842     252     1,084     733  
 
Income from continuing operations before income tax provision 3,679 1,763 16,575 10,140
Income tax provision (benefit)   748     (1,407 )   3,324     1,302  
Income from continuing operations 2,931 3,170 13,251 8,838
Discontinued operations
(Loss) income from discontinued operations before income tax provision (369 ) (64 ) 393
Gain on sale of discontinued operations 29,489
Income tax provision (benefit)   141     (1,147 )   10,459     (773 )
(Loss) income from discontinued operations   (141 )   778     18,966     1,166  
Net Income $ 2,790   $ 3,948   $ 32,217   $ 10,004  
 

Earnings per share – basic:

Continuing operations $ 0.09 $ 0.10 $ 0.41 $ 0.27
Discontinued operations         0.02     0.59     0.04  

Earnings per share – basic

$ 0.09   $ 0.12   $ 1.00   $ 0.31  
 

Earnings per share – diluted:

Continuing operations $ 0.09 $ 0.10 $ 0.41 $ 0.27
Discontinued operations       0.02     0.59     0.04  

Earnings per share – diluted

$ 0.09   $ 0.12   $ 1.00   $ 0.31  
 
Weighted average shares of common stock outstanding:
Basic   32,325     31,902     32,264     31,861  
Diluted   32,416     32,236     32,335     32,196  
Dividends declared per share $   $   $ 1.00   $  
 
 
 
 
 
 

HEALTHSTREAM, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)

 
    December 31,  

December 31,

2018

2017(1)

ASSETS
Current assets:
Cash and cash equivalents $ 134,321 $ 84,768
Marketable securities 34,497 46,350
Accounts and unbilled receivables, net 41,004 38,018
Prepaid and other current assets 31,612 24,467
Current assets of discontinued operations       6,125  
Total current assets 241,434 199,728
 
Capitalized software development, net 18,352 16,014
Property and equipment, net 14,084 8,092
Goodwill and intangible assets, net 145,522 154,641
Deferred tax assets 145 45
Deferred commissions 16,470
Other assets 4,159 4,526
Long-term assets of discontinued operations       28,073  
Total assets $ 440,166   $ 411,119  
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable, accrued and other liabilities $ 39,011 $ 29,356
Deferred revenue 66,061 64,938
Current liabilities of discontinued operations       6,772  
Total current liabilities 105,072 101,066
Deferred tax liabilities 11,068
Deferred revenue, non-current 2,868 6,287
Other long-term liabilities 2,211 1,048
Long-term liabilities of discontinued operations       2,548  
Total liabilities 121,219 110,949
 
Shareholders’ equity:
Common stock 286,597 282,666
Accumulated other comprehensive loss (23 ) (38 )
Retained earnings   32,373     17,542  
Total shareholders’ equity   318,947     300,170  
Total liabilities and shareholders' equity $ 440,166   $ 411,119  
 

(1) Derived from audited financial statements contained in the Company’s filing on Form 10-K for the year ended December 31, 2017, adjusted for the divestiture of the Patient Experience business segment.

 
 
 
 
 
 

HEALTHSTREAM, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

 
        Year Ended
December 31,     December 31,
2018 2017
Operating activities:
Net income $ 32,217 $ 10,004
Income from discontinued operations (18,966 ) (1,166 )
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 24,231 24,047
Amortization of deferred commissions 7,659
Share-based compensation 1,777 1,736
Deferred income taxes 3,017 (2,144 )
Provision for doubtful accounts 1,033 1,568
(Gain) loss on equity method investments (42 ) 5
Change in fair value of cost method investments 1,271
Other (9 ) 409
Changes in assets and liabilities:
Accounts and unbilled receivables (4,050 ) 1,125
Deferred commissions (11,577 )
Prepaid and other assets (2,329 ) 1,820
Accounts payable, accrued and other liabilities 4,915 5,752
Deferred revenue   5,103     (552 )
Net cash provided by continuing operating activities 44,250 42,604
Net cash (used in) provided by discontinued operating activities   (1,004 )   4,108  
Net cash provided by operating activities 43,246 46,712
 
Investing activities:
Proceeds from sale of discontinued operations, net of tax 44,049
Changes in marketable securities 11,907 6,794
Payments to acquire cost method investments (833 ) (500 )
Purchases of property and equipment (7,166 ) (5,515 )
Payments associated with capitalized software development   (11,284 )   (9,597 )
Net cash provided by (used in) continuing investing activities 36,673 (8,818 )
Net cash used in discontinued investing activities   (115 )   (2,761 )
Net cash provided by (used in) investing activities 36,558 (11,579 )
 
Financing activities:
Proceeds from exercise of stock options 2,582 413
Taxes paid related to net settlement of equity awards (338 ) (412 )
Payment of earn-out related to prior acquisitions (38 )
Payment of debt issuance costs (100 )
Payment of cash dividends   (32,357 )    
Net cash (used in) provided by financing activities (30,251 ) 1
 
Net increase in cash and cash equivalents 49,553 35,134
Cash and cash equivalents at beginning of period   84,768     49,634  
Cash and cash equivalents at end of period $ 134,321   $ 84,768  
 
 
 
 
 
 

Reconciliation of GAAP to Non-GAAP Financial Measures(1)
(In thousands)
(Unaudited)

 
    Three Months Ended

December 31,

  Year Ended

December 31,

2018   2017 2018   2017
GAAP income from continuing operations $ 2,931 $ 3,170 $ 13,251 $ 8,838
Interest income (859 ) (287 ) (2,444 ) (870 )
Interest expense 32 35 130 132
Income tax provision (benefit) 748 (1,407 ) 3,324 1,302
Stock based compensation expense 472 495 1,777 1,736
Depreciation and amortization 6,134 6,173 24,231 24,047
Change in fair value of cost method investments           1,271      
Adjusted EBITDA from continuing operations $ 9,458   $ 8,179   $ 41,540   $ 35,185  
 
GAAP net income $ 2,790 $ 3,948 $ 32,217 $ 10,004
Interest income (859 ) (287 ) (2,444 ) (870 )
Interest expense 32 35 130 131
Income tax provision (benefit) 889 (2,554 ) 13,783 529
Stock based compensation expense 472 493 1,686 1,852
Depreciation and amortization 6,134 6,794 24,412 26,283
Change in fair value of cost method investments           1,271      
Adjusted EBITDA $ 9,458   $ 8,429   $ 71,055   $ 37,929  
 
GAAP operating income $ 2,837 $ 1,511 $ 15,491 $ 9,407
Adjustment for deferred revenue write-down   108     82     887     1,621  
Non-GAAP operating income $ 2,945   $ 1,593   $ 16,378   $ 11,028  
 
GAAP net income $ 2,790 $ 3,948 $ 32,217 $ 10,004
Adjustment for deferred revenue write-down, net of tax   86     148     709     1,413  
Non-GAAP net income $ 2,876   $ 4,096   $ 32,926   $ 11,417  
 

(1) This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, adjusted EBITDA, and adjusted EBITDA from continuing operations, which are used by management in analyzing its financial results and ongoing operational performance.

 
 
 
 
 
 

Impact of Adoption of ASC 606 (Unaudited)

 
        Three Months Ended

December 31,

2018     2017

ASC 606

As reported

   

Adjustments

from ASC

606 to ASC

605

 

ASC 605

As adjusted

ASC 605
Revenue $ 59,825 $ (342 ) $ 60,167 $ 55,269
Operating income 2,837 897 1,940 1,511
Income from continuing operations 2,931 877 2,054 3,170
Adjusted EBITDA from continuing operations 9,458 897 8,561 8,179
Non-GAAP operating income 2,945 897 2,048 1,593
 
 
Year Ended

December 31,

2018 2017

ASC 606

As reported

Adjustments

from ASC

606 to ASC

605

ASC 605

As adjusted

ASC 605

Revenue $ 231,616 $ 740 $ 230,876 $ 214,899
Operating income 15,491 3,747 11,744 9,407
Income from continuing operations 13,251 2,991 10,260 8,838
Adjusted EBITDA from continuing operations 41,540 3,747 37,793 35,185
Non-GAAP operating income 16,378 3,747 12,631 11,028
 
 
 
 
 
 

This press release includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for the financial performance for 2019, that involve risks and uncertainties regarding HealthStream. These statements are based upon management’s beliefs, as well as assumptions made by and data currently available to management. This information has been, or in the future may be, included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by the forward-looking statements, including, without limitation, as the result of risks referenced in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed on February 26, 2018, and in the Company’s other filings with the Securities and Exchange Commission from time to time. Consequently, such forward-looking information should not be regarded as a representation or warranty or statement by the Company that such projections will be realized. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to update or revise any such forward-looking statements.

Gerard M. Hayden, Jr.
Chief Financial Officer
(615) 301-3163
ir@healthstream.com

Media:
Mollie Condra, Ph.D.
Vice President, Investor Relations & Communications
(615) 301-3237
mollie.condra@healthstream.com

Source: HealthStream, Inc.